MacroGenics, Inc. (MGNX)
4.135
+0.06
(+1.35%)
USD |
NASDAQ |
Aug 28, 16:00
4.03
-0.10
(-2.54%)
After-Hours: 20:00
MacroGenics Total Liabilities (Quarterly) : 302.54M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 302.54M |
| March 31, 2026 | 196.68M |
| December 31, 2025 | 208.98M |
| September 30, 2025 | 203.76M |
| June 30, 2025 | 198.80M |
| March 31, 2025 | 145.45M |
| December 31, 2024 | 154.50M |
| September 30, 2024 | 144.43M |
| June 30, 2024 | 143.32M |
| March 31, 2024 | 142.13M |
| December 31, 2023 | 154.21M |
| September 30, 2023 | 145.99M |
| June 30, 2023 | 134.11M |
| March 31, 2023 | 234.23M |
| December 31, 2022 | 147.50M |
| September 30, 2022 | 72.39M |
| June 30, 2022 | 75.56M |
| March 31, 2022 | 93.23M |
| December 31, 2021 | 95.63M |
| September 30, 2021 | 100.72M |
| June 30, 2021 | 106.87M |
| March 31, 2021 | 84.91M |
| December 31, 2020 | 82.86M |
| September 30, 2020 | 82.80M |
| June 30, 2020 | 79.81M |
| Date | Value |
|---|---|
| March 31, 2020 | 74.84M |
| December 31, 2019 | 81.87M |
| September 30, 2019 | 96.25M |
| June 30, 2019 | 89.23M |
| March 31, 2019 | 94.02M |
| December 31, 2018 | 89.25M |
| September 30, 2018 | 72.71M |
| June 30, 2018 | 74.86M |
| March 31, 2018 | 78.80M |
| December 31, 2017 | 74.64M |
| September 30, 2017 | 52.38M |
| June 30, 2017 | 43.50M |
| March 31, 2017 | 40.08M |
| December 31, 2016 | 42.51M |
| September 30, 2016 | 39.76M |
| June 30, 2016 | 38.87M |
| March 31, 2016 | 39.40M |
| December 31, 2015 | 45.93M |
| September 30, 2015 | 44.76M |
| June 30, 2015 | 42.51M |
| March 31, 2015 | 47.08M |
| December 31, 2014 | 52.60M |
| September 30, 2014 | 54.54M |
| June 30, 2014 | 63.74M |
| March 31, 2014 | 56.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| Xencor, Inc. | 221.73M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 345.41M |
| Shareholders Equity (Quarterly) | 42.87M |
| Debt to Equity Ratio | 4.624 |
| Current Ratio | 2.956 |
| Net Debt Paydown Yield | -10.94% |